The TNF-α+CV-A16 group presented the most severe clinical symptoms, the lowest survival rate and the most severe pathological changes in brain tissue (Figure 5), but Anti-TNF-α treatment before CV-A16 infection resulted in not only a significant reduction in the clinical symptoms and the degree of pathological injury, but also a significant reduction in the mortality of suckling mice. Here, TNF is linked to infection.